Compare AMBO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBO | EDSA |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9M | 12.8M |
| IPO Year | 2010 | N/A |
| Metric | AMBO | EDSA |
|---|---|---|
| Price | $4.18 | $1.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 18.9K | ★ 29.0K |
| Earning Date | 08-05-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $9,699,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.07 | ★ N/A |
| Revenue Growth | ★ 23.73 | N/A |
| 52 Week Low | $1.32 | $1.55 |
| 52 Week High | $6.75 | $4.49 |
| Indicator | AMBO | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 43.84 |
| Support Level | $4.12 | $1.67 |
| Resistance Level | $5.25 | $1.78 |
| Average True Range (ATR) | 0.53 | 0.07 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 33.12 | 68.73 |
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.